Abstract:ABSTRACT We have previously shown that poly(I:C) activates murine hepatic cells to produce interferon (IFN) and suppresses hepatitis B virus (HBV) replication in vitro . Therefore, we addressed whether poly(I:C) is able to induce the clearance of HBV in vivo . The chronic HBV replication mouse model was established by the hydrodynamic injection (HI) of pAAV-HBV1.2 into the tail veins of wild-type and IFN-α/βR-, IFN-γ-, and CXCR3-deficient C57BL/6 mice. Fourteen days post-HI of pAAV-HBV1.2, mice were administered poly(I:C) by intraperitoneal injection, intramuscular injection, or HI. Only treatment of poly(I:C) by HI led to HBV clearance in wild-type C57BL/6 mice. Serum HBsAg disappeared within 40 days postinfection (dpi) in mice that received poly(I:C) by HI, and this was accompanied by the appearance of anti-HBs antibodies. HBV-specific T-cell and antibody responses were significantly enhanced by HI of poly(I:C). HBV replication intermediates and HBcAg-positive hepatocytes were eliminated in the liver. HI of poly(I:C) induced the production of IFNs in mice and enhanced the levels of cytokines, IFN-stimulated genes, and T-cell markers in the liver. Importantly, poly(I:C)-induced HBV clearance was impaired in IFN-α/βR-, IFN-γ-, and CXCR3-deficient mice, indicating that the induction of type I IFN and the stimulation and recruitment of T cells into the liver are essential for HBV clearance in this model. Taken together, the application of poly(I:C) by HI into the liver enhances innate and adaptive immune responses and leads to HBV clearance in an HBV mouse model, implicating the potential of intrahepatic Toll-like receptor 3 (TLR3) activation for the treatment of chronic hepatitis B patients. IMPORTANCE It has become well accepted that immunomodulation is a potentially useful approach to treat chronic viral infection. Recently, combinations of antiviral treatment and therapeutic vaccinations were evaluated for therapies of chronic hepatitis B virus (HBV) infection. Activation of the innate immune branch may also be important for viral control and contributes to HBV clearance. Our present study demonstrated that hepatic TLR3 activation led to clearance of hepatitis B virus in an HBV mouse model. For the first time, we showed that HBV clearance in this model is dependent not only on type I interferon (IFN) but also on type II IFN, indicating a coordinated action of innate and adaptive immune responses. T-cell recruitment appeared to be critical for the success of TLR3-mediated antiviral action. These findings implicate the potential of intrahepatic TLR3 activation for the treatment of chronic HBV infection.

Lipopolysaccharide-Induced Innate Immune Responses in Primary Hepatocytes Downregulates Woodchuck Hepatitis Virus Replication Via Interferon-Independent Pathways

The Expression of PD-1 Ligands and Their Involvement in Regulation of T Cell Functions in Acute and Chronic Woodchuck Hepatitis Virus Infection

Toll-like Receptor Dependent Innate Immune Responses by Primary Mouse Hepatocytes and Its Control of HBV Replication

HBV Inhibits LPS-induced NLRP3 Inflammasome Activation and IL-1β Production Via Suppressing the NF-κB Pathway and ROS Production.

RNAi induces innate immunity through multiple cellular signaling pathways

Agonistic Activation of Cytosolic DNA Sensing Receptors in Woodchuck Hepatocyte Cultures and Liver for Inducing Antiviral Effects

Inhibition of Woodchuck Hepatitis Virus Gene Expression in Primary Hepatocytes by Sirna Enhances the Cellular Gene Expression

Enhancing Virus-Specific Immunity in Vivo by Combining Therapeutic Vaccination and PD-L1 Blockade in Chronic Hepadnaviral Infection

Pathological Role of Interleukin-17 in Poly I:C-Induced Hepatitis

Molecular Characterization of Woodchuck Interleukin-10 Receptor and Enhanced Function of Specific T Cells from Chronically Infected Woodchucks Following Its Blockade

Hepatitis C Virus Impairs TLR3 Signaling and Inhibits IFN-λ 1 Expression in Human Hepatoma Cell Line

Molecular Cloning, Characterization and Expression Analysis of Woodchuck Retinoic Acid-Inducible Gene I

Role of Toll-like Receptor 2 in the Immune Response Against Hepadnaviral Infection

Woodchuck Hepatitis Virus Core Antigen-Based DNA and Protein Vaccines Induce Qualitatively Different Immune Responses That Affect T Cell Recall Responses and Antiviral Effects.

Retinoic acid inducible gene-I (RIG-I) signaling of hepatic stellate cells inhibits hepatitis C virus replication in hepatocytes

Immunomodulation As an Option for the Treatment of Chronic Hepatitis B Virus Infection: Preclinical Studies in the Woodchuck Model

Combination Therapy Including CpG Oligodeoxynucleotides and Entecavir Induces Early Viral Response and Enhanced Inhibition of Viral Replication in a Woodchuck Model of Chronic Hepadnaviral Infection.

Poly(I:C) Treatment Leads to Interferon-Dependent Clearance of Hepatitis B Virus in a Hydrodynamic Injection Mouse Model.

Molecular characterization of the type I IFN receptor in two woodchuck species and detection of its expression in liver samples from woodchucks infected with woodchuck hepatitis virus (WHV)

TLR3 Activation of Hepatic Stellate Cell Line Suppresses HBV Replication in HepG2 Cells

Molecular characterization of woodchuck IFI16 and AIM2 and their expression in woodchucks infected with woodchuck hepatitis virus (WHV)